510(k) K091766
K091766 is an FDA 510(k) premarket notification submitted by Binax, Inc. for the device "CLEARVIEW EXACT PBP2A TEST, MODEL 891-000". The FDA issued a decision of Substantially Equivalent on February 24, 2010. The device falls under product code MYI (System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies), a Class II device regulated under 21 CFR 866.1640. Binax, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 24, 2010
- Date Received
- June 17, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type